Purpose: To identify the anatomical and technical factors associated with unintended nephrostomy catheter dislodgement (NCD). Materials and Methods: A retrospective review of 742 percutaneous nephrostomy (PCN) procedures carried out between June 2020 and June 2024 was conducted. Thirty-eight patients with spontaneous NCD were assigned to the dislodgement group, and 38 matched controls were selected using propensity score matching.. Key measurements included cortex-to-skin distance, paravertebral muscle area, psoas muscle area, subcutaneous fat thickness, and renal parenchymal thickness. Results: Patients with NCD were similar in age and sex. No significant differences were observed in subcutaneous fat thickness, muscle thickness, or renal parenchymal thickness between the groups. However, cortex-to-skin distance was significantly shorter in the NCD group (p = 0.001). ROC analysis identified an optimal threshold of 46.65 mm for cortex-to-skin distance, with a sensitivity of 92.1%, specificity of 39.5%, and a positive predictive value of 60.3% (AUC = 0.67). Conclusion: Shorter cortex-to-skin distance is a key predictor of NCD. Patients with shorter cortex-to-skin distances, may benefit from closer monitoring and targeted preventive measures to reduce the risk of dislodgement. Graphical
Aim: This study aimed to compare the safety, feasibility, and efficacy of liver venous deprivation (LVD) and portal vein embolization (PVE) in inducing future liver remnant (FLR) hypertrophy prior to major hepatectomy. Method: In this retrospective single-center study, 38 patients who underwent PVE (n=29) or LVD (n=9) between June 2020 and January 2025 were analyzed. Patients were selected based on small FLR volume requiring preoperative hypertrophy induction. Pre- and post-procedural liver volumetric measurements were performed using contrast-enhanced CT, and standardized FLR (sFLR) percentages were calculated. Clinical outcomes, including postoperative complications and mortality, were also evaluated. Results: Among 38 patients, 21 (15 PVE and 6 LVD) proceeded to surgery. Although pre-procedural sFLR percentages were similar between groups (19.5±2.0% for PVE vs. 19.9±2.6% for LVD; p=0.806), post-procedural sFLR percentages were significantly higher in the LVD group (33.4±5.1% vs. 24.5±5.1%, p=0.012). The mean degree of standardized FLR hypertrophy, expressed as an absolute percentage point increase was significantly greater in the LVD group (13.5% vs. 5%, p=0.009), and the percentage FLR increase was higher (68.6±20.7% vs. 24.7±15.6%, p=0.006). No significant differences were observed in postoperative complication rates (16.6% vs. 20%, p=0.601) or mortality (16.7% vs. 13.3%, p=0.847). Conclusion: LVD demonstrated superior FLR hypertrophy compared to PVE while maintaining a comparable safety profile. LVD may offer an effective alternative for patients with small baseline FLR volumes at high risk of insufficient liver regeneration. Further prospective studies are warranted to confirm these findings and define the optimal clinical indications for LVD.
Aim: The current study compared the efficacy and safety of retrograde pedal artery (PA) access versus conventional common femoral artery (CFA) access in managing isolated superficial femoral artery (SFA) occlusions or severe stenoses. Materials and Methods: A retrospective analysis was conducted on 34 patients treated between June 2020 and November 2023. The patients were categorized into two groups: 12 patients with PA access and 22 with CFA access. Technical success, complication rates, stent usage, procedure duration, and radiation doses were analyzed. Results: Technical success was achieved in 92.8% of the patients in the PA access group and 84% of the CFA access group (p = 0.636). Complications at the access site were significantly lower in the PA access group, with no hematomas or pseudoaneurysms observed, while both hematomas (32%) and pseudoaneurysms (16%) were noted in the CFA group (p = 0.033). Stent usage was similar between the two groups (21.4% PA vs. 28% CFA, p = 0.721). Median procedure durations were 43 minutes (IQR 27.5–59) for PA and 47 minutes (IQR 29–64) for CFA (p = 0.446). Median total air kerma dose was 280 mGy (IQR 166.5–326.75) for PA and 225 mGy (IQR 145–489) for CFA (p = 0.826). Conclusions: Retrograde PA access is a viable and safe alternative to CFA access, particularly for patients with complex femoral anatomy, offering similar efficacy with fewer access site complications.
Objective: The current study aimed to compare the technical success, safety, and efficacy of carotid artery stenting (CAS) in patients with carotid near-occlusion without collapse with patients with severe carotid stenosis. The findings can provide insight into the clinical implications of treating near-occlusion without collapse as a distinct pathological entity. Methods: A retrospective evaluation was conducted on 50 patients who had undergone CAS: 25 patients with carotid near-occlusion without collapse (Group 1) and 25 age- and sex-matched controls with severe carotid stenosis (≥70%) (Group 2). Diagnosis of near-occlusion was based on digital subtraction angiography findings, following established criteria, and all procedures were performed electively. Technical success, peri-procedural complications, and long-term outcomes were evaluated. The study focused on angiographic features, stent types, complications, and restenosis rates in the Group 1 patients. Results: A comparable technical success rate (100%) was observed between the two study groups. In Group 1, periprocedural events were observed in three patients: two developed hypotension requiring adrenergic support, and one experienced bradycardia lasting 24 hours. In Group 2, two patients developed hypotension requiring medical treatment. Peri-procedural complications occurred in 8% and 12% of patients in Groups 1 and 2, respectively, with no significant difference (p=0.637). A median follow-up of 22.5 months in Group 1 and 28 months in Group 2 indicated symptomatic stroke rates of 4% in both groups, with no new symptomatic ischemic strokes observed beyond the peri-procedural period. Conclusions: CAS in patients with near-occlusion without collapse demonstrated outcomes comparable to those with severe carotid stenosis, with similar rates of technical success, complications, and long-term efficacy.